More or Less is produced in partnership with the Open University. Presenter: Tim Harford Reporter: Lizzy McNeill Producer: ...

To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

The advice to “eat less, move more” isn’t just outdated, it’s harmful. Obesity is a chronic condition shaped by biology, ...

For many years, health experts have been concerned about "food deserts," places where residents lack good nutritional options ...

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...

About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

Mouse livers were engineered via a one-time genome editing to secrete a GLP-1, cutting weight gain and improving glucose ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...